Aardvark Therapeutics, Inc.
AARD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001774857
In the last 90 days, Aardvark Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 71 institutions reported holding it in 13F filings for Q2 2026, worth $54.3M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Aardvark Therapeutics, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 35 | 49 | +14 |
| Shares | 8.92M | 9.46M | +545.2K (+6.1%) |
| Value | $120.5M | $125.7M | +$5.20M (+4.3%) |
New holders (15)
Institutions that held Aardvark Therapeutics, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 319,623 | $4.25M | 0.00% |
| Cresset Asset Management, LLC | 141,783 | $1.88M | 0.01% |
| Two Sigma Investments, LP | 63,569 | $844.8K | 0.00% |
| Two Sigma Advisers, LP | 25,700 | $341.6K | 0.00% |
| Bridgeway Capital Management, LLC | 22,000 | $292.4K | 0.01% |
| Jane Street Group, LLC | 19,447 | $258.5K | 0.00% |
| Bank of New York Mellon Corp | 15,523 | $206.3K | 0.00% |
| Police & Firemen's Retirement System of New Jersey | 2,120 | $28.2K | 0.00% |
| Stone House Investment Management, LLC | 1,000 | $13.3K | 0.00% |
| Russell Investments Group, Ltd. | 469 | $6.23K | 0.00% |
| FMR LLC | 363 | $4.82K | 0.00% |
| The PNC Financial Services Group, Inc. | 140 | $1.86K | 0.00% |
| EverSource Wealth Advisors, LLC | 60 | $797 | 0.00% |
| SRS Capital Advisors, Inc. | 21 | $280 | 0.00% |
| CWM, LLC | 15 | $0 | 0.00% |
Sold out (1)
Institutions that held Aardvark Therapeutics, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Cormorant Asset Management, LP | 800,189 | $10.8M |